An observational study in Myocardial Injury and Acuter Kidney Injury, sponsored by Hao Li. Completed. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-08-15.
Sponsored by Hao Li · Observational
We aimed to explore the influence of ABT on the incidence of MINS, AKI, and overall prognosis among advanced-age HCC patients who underwent hepatectomy
Hao Li is the lead sponsor of 4 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
age ≥65 years old patients
Patients over 65 years with HCC undergoing elective surgery between January 2016 and December 2018
Exclusion Criteria:
ASA grade V requiring repeat surgery within 1 week losing to follow-up and/or those with >5% missing data
the incidence of MINS within postoperative 30 days
Time frame: postoperative day 1-30
overall survival (OS)
the time from the date of surgery to the date of death
Time frame: postoperative day 1-30
postoperative 7-day AKI
Time frame: postoperative day 1-7
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hao Li